Phase II trial of carboplatin plus cetuximab for the treatment of stage IIIB/IV non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Bradford, D. S.
Socinski, M. A.
LaRocca, R. V.
Hensing, T. A.
Bordoni, R. E.
机构：
[1] Highlands Oncol Grp, Fayetteville, AR USA
[2] Univ N Carolina, Chapel Hill, NC 27515 USA
[3] Kentuckiana Canc Inst, Louisville, KY USA
[4] Evanston Northwestern Healthcare, Evanston, IL USA
[5] Georgia Canc Specialists, Marietta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18005
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Randomized phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small cell lung cancer (NSCLC)
    Saleh, M. N.
    Socinski, M. A.
    Trent, D.
    Dobbs, T.
    Zehngebot, L. M.
    Levine, M. A.
    Stella, P. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Results of a phase I/II trial of carboplatin/gemcitabine plus celecoxib for first-line treatment of stage IIIB/IV non-small cell lung cancer (NSCLC).
    Burton, JD
    El-Sayah, D
    Cherry, M
    Bhargava, M
    Terjanian, T
    Odaimi, M
    Vesoniaraki, M
    Lowry, J
    Forte, F
    Friscia, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [3] Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC):: a multicentre phase II clinical trial
    Palmeri, S
    Leonardi, V
    Gebbia, V
    De Bella, MT
    Ferraù, F
    Faillù, G
    Spatafora, M
    Valenza, R
    Di Vita, G
    Vitello, S
    Carroccio, R
    Sciortino, G
    Vaglica, M
    Accurso, V
    Agostara, B
    Licata, G
    [J]. LUNG CANCER, 2001, 34 (01) : 115 - 123
  • [4] A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC)
    Socinski, M. A.
    Saleh, M. N.
    Trent, D. F.
    Dobbs, T. W.
    Zehngebot, L. M.
    Levine, M. A.
    Bordoni, R.
    Stella, P. J.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (06) : 1068 - 1073
  • [5] Pemetrexed plus carboplatin versus gemcitabine plus carboplatin in the treatment of stage IIIB/IV non-small cell lung cancer
    Gronberg, B. H.
    Bremnes, R.
    Aasebo, U.
    Brunsvig, P.
    Flotten, O.
    Hjelde, H.
    Wammer, F.
    Stornes, F.
    Tollali, T.
    Sundstrom, S. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] A phase II trial of alternating cycles of carboplatin/paclitaxel and carboplatin/gemcitabine for stage IIIB/IV non-small cell lung cancer
    Ahmad, I.
    Arnold, F.
    Ahmed, S.
    Sami, A.
    Zhu, T.
    Haider, K.
    Yadav, S.
    Gesy, K.
    Brigden, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Update of a phase I/II trial of carboplatin/gemcitabine plus escalating doses of celecoxib for first-line treatment of stage IIIB/IV non-small cell lung cancer (NSCLC).
    Burton, JD
    Badine, E
    El-Sayah, D
    Dib, E
    Forte, F
    Terjanian, T
    Odaimi, M
    Vesoniaraki, M
    Friscia, P
    Lowry, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 700S - 700S
  • [8] A multicenter phase II trial with gemcitabine (GEM) and vinorelbine (VNR) in the treatment of non-small cell lung cancer (NSCLC) stage IIIB and IV
    Laack, E
    Mende, T
    Saal, JG
    Chemaissani, A
    Scholtze, J
    Lorenz, C
    Dalhoff, K
    Hossfeld, DK
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S252 - S252
  • [9] Phase II trial of ipilimumab (IPI) and paclitaxel/carboplatin (P/C) in first-line stage IIIb/IV non-small cell lung cancer (NSCLC).
    Lynch, T. J.
    Bondarenko, I. N.
    Luft, A.
    Serwatowski, P.
    Barlesi, F.
    Chacko, R. T.
    Sebastian, M.
    Siegel, J.
    Cuillerot, J.
    Reck, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Phase II study of navelbine and carboplatin in stage IIIB and IV non small cell lung cancer
    Chetiyawardana, AD
    Grove, N
    Faulk, S
    [J]. THORAX, 2001, 56 : 69 - 69
12345